Abstract
Adolescent depression is a growing challenge nationwide with high morbidity and suicidality. We highlight results of the first multicenter double blinded active vs sham trial of TMS to treat adolescents with major depressive disorder (MDD).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
